Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial to investigate ADX71441 for the treatment of cocaine use disorder

Trial Profile

A clinical trial to investigate ADX71441 for the treatment of cocaine use disorder

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Jan 2019

At a glance

  • Drugs ADX 71441 (Primary)
  • Indications Cocaine abuse
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jan 2019 According to an Addex Therapeutics media release, the company plans to enter phase 1 trial during Q2 2019.
    • 05 Oct 2017 New trial record
    • 03 Oct 2017 According to an Addex Therapeutics media release, this trial will be conducted in coordination with the Friends Research Institute (FRI) and principal investigator, Dr. Frank J. Vocci. The studies are expected to begin in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top